Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea.

Vervoort J, Gazin M, Kazma M, Kotlovsky T, Lammens C, Carmeli Y, Goossens H, Malhotra-Kumar S; SATURN WP1 and MOSAR WP2 study groups..

Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2215-21. doi: 10.1007/s10096-014-2193-9. Epub 2014 Jul 4.

PMID:
24993152
2.

Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.

Crémet L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D, Corvec S.

Pathol Biol (Paris). 2011 Jun;59(3):151-6. doi: 10.1016/j.patbio.2009.04.003. Epub 2009 May 29.

PMID:
19481883
3.

Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.

Kanamori H, Navarro RB, Yano H, Sombrero LT, Capeding MR, Lupisan SP, Olveda RM, Arai K, Kunishima H, Hirakata Y, Kaku M.

Acta Trop. 2011 Oct-Nov;120(1-2):140-5. doi: 10.1016/j.actatropica.2011.07.007. Epub 2011 Jul 28.

PMID:
21820398
4.

High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase.

Shibl AM, Al-Agamy MH, Khubnani H, Senok AC, Tawfik AF, Livermore DM.

Diagn Microbiol Infect Dis. 2012 Aug;73(4):350-3. doi: 10.1016/j.diagmicrobio.2012.04.005. Epub 2012 May 25.

PMID:
22633335
5.

Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase-producing Enterobacteriaceae isolates in Mexico.

Silva-Sanchez J, Barrios H, Reyna-Flores F, Bello-Diaz M, Sanchez-Perez A, Rojas T; Bacterial Resistance Consortium., Garza-Ramos U.

Microb Drug Resist. 2011 Dec;17(4):497-505. doi: 10.1089/mdr.2011.0086. Epub 2011 Aug 11.

PMID:
21834663
6.

Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.

Dolejska M, Brhelova E, Dobiasova H, Krivdova J, Jurankova J, Sevcikova A, Dubska L, Literak I, Cizek A, Vavrina M, Kutnikova L, Sterba J.

Int J Antimicrob Agents. 2012 Dec;40(6):510-5. doi: 10.1016/j.ijantimicag.2012.07.016. Epub 2012 Oct 6.

PMID:
23043911
7.

Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE.

Paltansing S, Kraakman ME, Ras JM, Wessels E, Bernards AT.

J Antimicrob Chemother. 2013 Jan;68(1):40-5. doi: 10.1093/jac/dks365. Epub 2012 Sep 18.

PMID:
22991424
8.

[Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].

Piekarska K, Rzeczkowska M, Zacharczuk K, Chróst A, Januszkiewicz A, Bareja E, Olak M, Gierczyński R.

Med Dosw Mikrobiol. 2012;64(3):211-9. Polish.

PMID:
23285775
9.

High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.

Ma J, Zeng Z, Chen Z, Xu X, Wang X, Deng Y, Lü D, Huang L, Zhang Y, Liu J, Wang M.

Antimicrob Agents Chemother. 2009 Feb;53(2):519-24. doi: 10.1128/AAC.00886-08. Epub 2008 Oct 20.

10.

Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R.

J Clin Microbiol. 2004 Oct;42(10):4769-75.

11.

Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.

Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A, Bareja E, Olak M, Gierczyński R.

Int J Antimicrob Agents. 2015 Mar;45(3):238-43. doi: 10.1016/j.ijantimicag.2014.09.019. Epub 2014 Nov 13.

PMID:
25468717
12.

Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.

Hassan WM, Hashim A, Domany R.

Indian J Med Microbiol. 2012 Oct-Dec;30(4):442-7. doi: 10.4103/0255-0857.103766.

13.

Characterization of plasmid-mediated quinolone resistance (PMQR) genes in extended-spectrum β-lactamase-producing Enterobacteriaceae pediatric clinical isolates in Mexico.

Silva-Sánchez J, Cruz-Trujillo E, Barrios H, Reyna-Flores F, Sánchez-Pérez A; Bacterial Resistance Consortium., Garza-Ramos U.

PLoS One. 2013 Oct 17;8(10):e77968. doi: 10.1371/journal.pone.0077968. eCollection 2013.

14.

Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Lonchel CM, Melin P, Gangoué-Piéboji J, Assoumou MC, Boreux R, De Mol P.

Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):79-87. doi: 10.1007/s10096-012-1717-4. Epub 2012 Aug 11.

PMID:
22886058
15.

[Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria].

Meradi L, Djahoudi A, Abdi A, Bouchakour M, Perrier Gros Claude JD, Timinouni M.

Pathol Biol (Paris). 2011 Aug;59(4):e73-8. doi: 10.1016/j.patbio.2009.05.003. Epub 2009 Nov 5. French.

PMID:
19896287
16.

Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar.

Rakotonirina HC, Garin B, Randrianirina F, Richard V, Talarmin A, Arlet G.

BMC Microbiol. 2013 Apr 17;13:85. doi: 10.1186/1471-2180-13-85.

17.

Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase-producing Enterobacteriaceae in a Tunisian hospital.

Ferjani S, Saidani M, Amine FS, Boutiba-Ben Boubaker I.

Microb Drug Resist. 2015 Apr;21(2):158-66. doi: 10.1089/mdr.2014.0053. Epub 2014 Sep 23.

PMID:
25247633
18.

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.

Reuland EA, Sonder GJ, Stolte I, Al Naiemi N, Koek A, Linde GB, van de Laar TJ, Vandenbroucke-Grauls CM, van Dam AP.

Clin Microbiol Infect. 2016 Aug;22(8):731.e1-7. doi: 10.1016/j.cmi.2016.05.003. Epub 2016 May 17.

PMID:
27223840
19.

Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.

Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MC, Melin P, De Mol P.

BMC Infect Dis. 2012 Mar 9;12:53. doi: 10.1186/1471-2334-12-53.

20.

Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium.

Paniagua R, Valverde A, Coque TM, Baquero F, Cantón R.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):376-9. doi: 10.1016/j.diagmicrobio.2010.03.012.

PMID:
20638607

Supplemental Content

Support Center